GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » TransMedics Group Inc (STU:TMDX) » Definitions » Institutional Ownership

TransMedics Group (STU:TMDX) Institutional Ownership : 81.89% (As of May. 17, 2024)


View and export this data going back to 2023. Start your Free Trial

What is TransMedics Group Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, TransMedics Group's institutional ownership is 81.89%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, TransMedics Group's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, TransMedics Group's Float Percentage Of Total Shares Outstanding is 81.61%.


TransMedics Group Institutional Ownership Historical Data

The historical data trend for TransMedics Group's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TransMedics Group Institutional Ownership Chart

TransMedics Group Historical Data

The historical data trend for TransMedics Group can be seen below:

2023-05-31 2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29
Institutional Ownership 79.69 83.01 82.47 82.54 87.37 84.47 84.78 84.88 81.54 81.89

TransMedics Group Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


TransMedics Group (STU:TMDX) Business Description

Traded in Other Exchanges
Address
200 Minuteman Road, Andover, MA, USA, 01810
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body.